AMLX · Healthcare · $3.2B
Pre-market $29.18+0.27%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 463 Biotechnology peers
Quarterly Revenue Growth
“이번 분기는 실적보다 임상 결과 대기가 핵심이에요 — 마지막 환자 방문이 완료됐고 8월 말~9월 초 핵심 3상(LUCIDITY) 데이터 발표를”
In the company's words · 2026 2분기 earnings call